September 1, 2025
Germany’s cannabis landscape entered a new era in 2024 with the landmark Cannabis Act (CanG), enabling decriminalization and personal possession under “Pillar 1,” as well as empowering non-profit cultivation clubs. But for commercial operators, investors, and policymakers, the true test lies ahead: will “Pillar 2”—the long-anticipated commercial pilot projects for adult-use retail—launch in 2025 as many have hoped? And if so, what will cannabis compliance look like under this experimental regime?
As of September 2025, Germany’s “Pillar 2” stands at a crossroads. Federal-level uncertainty and diverging state positions have left the future of pilot model projects hanging in the balance. Yet with dozens of municipalities and Länder (“federal states”) actively submitting proposals—and some Berlin districts and major cities announcing pilot ambitions—industry stakeholders need clear insights on the status, feasibility, and likely regulations for these game-changing initiatives.
The “Pillar 2” framework envisions federally approved, scientifically supervised pilot projects in selected municipalities, allowing strictly limited adult-use cannabis sales through designated retailers or pharmacies. The aims are to gather real-world data, evaluate public health impacts, and inform future regulation of nationwide commercial sales.
After the CanG’s passage in April 2024, multiple German cities—led by Berlin, Frankfurt am Main, and Hanover—issued statements of intent to launch pilot programs as early as 2025 (source). Reports confirm that by late summer 2025, as many as 49 pilot applications had been submitted by municipalities to the Federal Office for Agriculture and Food (BLE), the key regulatory gatekeeper.
However, the process has encountered delays. Federal officials have yet to finalize the legal framework for commercial sales pilots as initially conceived under Pillar 2. Some early proposals—including one in Central Holstein—were even rejected by BLE due to non-compliance or insufficient scientific rigor (details). Meanwhile, federal ministries continue to debate the scope and design of these pilot programs, with the BMEL (Federal Ministry of Food and Agriculture) and the Federal Ministry of Health frequently cited as bottlenecks for approvals and compliance standards.
Any municipality or district wishing to launch a Pillar 2 commercial project must submit a detailed application to the BLE (source). Prospective pilot sites must demonstrate:
While the exact rules for Germany’s Pillar 2 model projects are still pending federal publication, signs point to a tight, medical-style compliance regime. Likely requirements include:
Those seeking to operate under Pillar 2 should expect German medical cannabis standards as a minimum bar and prepare for heightened scrutiny. Consult up-to-date BLE guidance and maintain flexible compliance systems as regulations evolve.
The major uncertainty in 2025 is political. While Berlin, Frankfurt, and others push hard for retail pilots, federal officials signal that formal approvals and final compliance rules are unlikely before late 2025. Many observers now predict first legal pilot sales may slip to 2026 (overview).
Yet industry and municipal momentum hasn’t waned. The steady submission of new pilot proposals, local innovation, and public health collaborations suggest Germany is preparing methodically for a robust commercial test phase—once the political brakes are released.
While headline progress on commercial adult-use cannabis pilots in Germany remains slow and complex, the groundwork for a prudent, research-driven market test is taking shape. For those committed to cannabis compliance, licensing, and responsible retail, now is the time to track regulatory developments, build scientific alliances, and prepare for pilot launches that could set the tone for all of Europe.
Stay ahead of German cannabis regulations and compliance—use CannabisRegulations.ai for the latest legal updates, expertise, and business support.
References & Further Reading:
Germany’s cannabis landscape entered a new era in 2024 with the landmark Cannabis Act (CanG), enabling decriminalization and personal possession under “Pillar 1,” as well as empowering non-profit cultivation clubs. But for commercial operators, investors, and policymakers, the true test lies ahead: will “Pillar 2”—the long-anticipated commercial pilot projects for adult-use retail—launch in 2025 as many have hoped? And if so, what will cannabis compliance look like under this experimental regime?
As of September 2025, Germany’s “Pillar 2” stands at a crossroads. Federal-level uncertainty and diverging state positions have left the future of pilot model projects hanging in the balance. Yet with dozens of municipalities and Länder (“federal states”) actively submitting proposals—and some Berlin districts and major cities announcing pilot ambitions—industry stakeholders need clear insights on the status, feasibility, and likely regulations for these game-changing initiatives.
The “Pillar 2” framework envisions federally approved, scientifically supervised pilot projects in selected municipalities, allowing strictly limited adult-use cannabis sales through designated retailers or pharmacies. The aims are to gather real-world data, evaluate public health impacts, and inform future regulation of nationwide commercial sales.
After the CanG’s passage in April 2024, multiple German cities—led by Berlin, Frankfurt am Main, and Hanover—issued statements of intent to launch pilot programs as early as 2025 (source). Reports confirm that by late summer 2025, as many as 49 pilot applications had been submitted by municipalities to the Federal Office for Agriculture and Food (BLE), the key regulatory gatekeeper.
However, the process has encountered delays. Federal officials have yet to finalize the legal framework for commercial sales pilots as initially conceived under Pillar 2. Some early proposals—including one in Central Holstein—were even rejected by BLE due to non-compliance or insufficient scientific rigor (details). Meanwhile, federal ministries continue to debate the scope and design of these pilot programs, with the BMEL (Federal Ministry of Food and Agriculture) and the Federal Ministry of Health frequently cited as bottlenecks for approvals and compliance standards.
Any municipality or district wishing to launch a Pillar 2 commercial project must submit a detailed application to the BLE (source). Prospective pilot sites must demonstrate:
While the exact rules for Germany’s Pillar 2 model projects are still pending federal publication, signs point to a tight, medical-style compliance regime. Likely requirements include:
Those seeking to operate under Pillar 2 should expect German medical cannabis standards as a minimum bar and prepare for heightened scrutiny. Consult up-to-date BLE guidance and maintain flexible compliance systems as regulations evolve.
The major uncertainty in 2025 is political. While Berlin, Frankfurt, and others push hard for retail pilots, federal officials signal that formal approvals and final compliance rules are unlikely before late 2025. Many observers now predict first legal pilot sales may slip to 2026 (overview).
Yet industry and municipal momentum hasn’t waned. The steady submission of new pilot proposals, local innovation, and public health collaborations suggest Germany is preparing methodically for a robust commercial test phase—once the political brakes are released.
While headline progress on commercial adult-use cannabis pilots in Germany remains slow and complex, the groundwork for a prudent, research-driven market test is taking shape. For those committed to cannabis compliance, licensing, and responsible retail, now is the time to track regulatory developments, build scientific alliances, and prepare for pilot launches that could set the tone for all of Europe.
Stay ahead of German cannabis regulations and compliance—use CannabisRegulations.ai for the latest legal updates, expertise, and business support.
References & Further Reading:
